H-1B Filings
34
Major sponsor. DOL labor condition applications on file.
Management of Companies MA DOL H-1B OSHA ITA
Alexion Pharmaceuticals, Inc.: H-1B Sponsorship Profile
Alexion Pharmaceuticals, Inc. in MA (Management of Companies) is a sponsorship-and-safety profile: 34 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
Alexion Pharmaceuticals, Inc. (MA): · 34 H-1B LCAs at a $169,770 disclosed median · OSHA Grade A (DART 0.09)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Alexion Pharmaceuticals, Inc. in MA carries 34 H-1B wage filings on record, a $169,770 median wage across 32 disclosed-wage positions (above the $124,488 national median), a strong A OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
- 34 H-1B LCAs
- $169,770 median wage
- Grade A OSHA
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #1,437 of 51,370 sponsors in this corpus (about the 97th percentile), and disclosed median wage sits at the 79th percentile of 272,125 credible H-1B wage rows.
- 97th pct
- H-1B filing rank
- 79th pct
- median wage rank
- 63%
- safer on DART than
- 14%
- cleaner WARN history than
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
C+
Federal workforce composite
60/100
4 of 4 federal tracks · Alexion Pharmaceuticals, Inc.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Sponsorship scale A+
34 H-1B LCAs
#1,437 of 51,370 sponsors · 97th percentile by volume (DOL OFLC)
Disclosed pay B+
$169,770 median
79th percentile of 272,125 credible H-1B wage rows
Workplace safety C+
OSHA Grade A · DART 0.09
Safer than 63% of 214,554 employers with an OSHA ITA record
Layoff stability F
0 WARN notices
Cleaner WARN history than 14% of 304,376 tracked employers (state workforce agencies)
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
What changed between the two LCA fiscal years
- Alexion Pharmaceuticals, Inc.'s disclosed H-1B petition count fell from 19 in FY2024 to 6 in FY2025 (-68.4%).
- Alexion Pharmaceuticals, Inc.'s filing-count-weighted median disclosed H-1B wage fell from $184,348 in FY2024 to $136,625 in FY2025 (-25.9%).
Median H-1B Salary
$169,770
Above national median. Across 32 disclosed positions
OSHA Safety Grade
Grade A · DART 0.09
Safer than industry average. vs 0.33 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where Alexion Pharmaceuticals, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$169,770 Top 21% higher than 79% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Alexion Pharmaceuticals, Inc.'s H-1B median wage, FY2024 vs FY2025
Filing-count-weighted median across this employer's own disclosed H-1B positions (-25.9% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | Alexion Pharmaceuticals, Inc. | DOL OFLC / OSHA |
| Industry | Management of Companies | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 34 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $169,770 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.09 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
Alexion Pharmaceuticals, Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in MA (Management of Companies). In this corpus, H-1B filing volume ranks #1,437 of 51,370 sponsors in this corpus (about the 97th percentile); disclosed median wage sits at the 79th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 63% of 214,554 employers with an establishment injury record.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, Commercial Data Analytics and Reporting | $255,000 |
| Director, CMC Team Lead | $228,776 |
| Director, CMC Team Lead | $228,776 |
| Director, Study Start-Up and Site Partnerships | $228,000 |
| Associate Director, Commercial Data Analytics and Reporting | $201,058 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director, Clinical Supply Lead | $195,000 |
| Associate Director Development Asset Quality Meta | $194,324 |
| Associate Director, AI Diagnostics | $190,000 |
| Associate Director, Data Operations & Data Quality | $178,000 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $176,000 |
| Regulatory Publishing Manager | $170,100 |
| Regulatory Publishing Manager | $170,100 |
| Principal Engineer, Biologics Drug Substance Tech. Transfer | $170,000 |
| Associate Director, Research Collaborations and Alliances | $169,770 |
| Global/US Market Research & CI Partner | $166,842 |
| Sr. Mgr., Global Med Affairs Business Ops Partner | $166,448 |
| Senior Manager, Data Analytics and Insights | $164,815 |
| Senior Manager, Quality Management System Analytics | $163,613 |
| Manager, Biostatistics | $159,318 |
| Sr Scientist, Process Analytical Technologies & Chemometrics | $155,000 |
| Senior Engineer II, Injectable Drug Product Development | $145,000 |
| Scientist II, Injectable Drug Product Development | $142,766 |
| Scientist II | $141,008 |
| Development Scientist II, Analytical Dev & Clinical QC | $139,797 |
| Sr. Scientist I, Analytical Development and Clinical Supply | $135,000 |
| Development Scientist I, Analytical Dvlpmt and Clinical QC | $130,625 |
| Senior Engineer, Biologics Drug Substance Tech Transfer | $128,238 |
| Scientist I, Injectables Drug Product Development | $121,293 |
| PDCS Compliance Specialist | $106,605 |
| Associate Scientist III, Upstream Process Development | $96,900 |
What the Data Says About Alexion Pharmaceuticals, Inc.
Signature stat: H-1B volume
Alexion Pharmaceuticals, Inc.'s most extreme placement is sponsorship scale: 34 H-1B LCAs rank higher than 97% of sponsors in this corpus (#1,437 of 51,370).
Shrinking LCA footprint
FY2025 filings fell 68.4% from FY2024 (19 → 6).
Falling disclosed medians
Disclosed medians moved from $184,348 (FY2024) to $136,625 (FY2025) (-25.9%), weighted by this employer's own LCA rows — not a company-wide raise and not role-mix adjusted.
Top-quartile disclosed pay
Disclosed pay runs high: $169,770 median beats 79% of credible wage rows and sits above the $124,488 national median.
Safety near sector average
DART 0.1 tracks close to the 0.3 sector average (Grade A).
No WARN filings
No WARN Act mass-layoff notices are on file for Alexion Pharmaceuticals, Inc. among Management of Companies employers we track.
OSHA Safety Record
Grade A DART Rate: 0.09 (same-NAICS-sector avg: 0.33)
This employer DART rate (lower is safer)
Same NAICS-sector average
Alexion Pharmaceuticals, Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Management of Companies).
Total reported injuries on file: 3.
Where Alexion Pharmaceuticals, Inc. sits
This employer among Management of Companies H-1B peers
Across the 61 Management of Companies sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Alexion Pharmaceuticals, Inc. files more petitions than 72% of them and discloses a higher median wage than 87%, the high-volume, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (34 filings · $169,770 median here).
Each muted dot is one management of companies peer from a filings-stratified sample of 36; the brand marker is Alexion Pharmaceuticals, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
How Alexion Pharmaceuticals, Inc. compares to Management of Companies peers
Alexion Pharmaceuticals, Inc.'s nearest H-1B-filing peers in Management of Companies (home state MA). Each card links to that employer's federal-records profile.
Alexion Pharmaceuticals, Inc.
34 H-1B filings
JPMorgan Chase & Co.
1,353 H-1B filings
Humana Inc.
284 H-1B filings
What to check before working with Alexion Pharmaceuticals, Inc.
For Alexion Pharmaceuticals, Inc., read sponsorship pay (34 H-1B LCAs, median $169,770) next to the OSHA safety grade (A).
- H-1B median is $169,770 across 32 disclosed-wage positions (of 34 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
- Safety grade A reflects a DART rate read against the Management of Companies average of 0.33 - a relative benchmark, not an absolute verdict. How grades work
Alexion Pharmaceuticals, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Read with this employer
- JPMorgan Chase & Co. (IL) - 1,353 H-1B filings in the same Management of Companies roster
- Humana Inc. (KY) - 284 H-1B filings in the same Management of Companies roster
- Micron Technology, Inc. (ID) - 263 H-1B filings in the same Management of Companies roster
- Interpreting safety grades - how Alexion Pharmaceuticals, Inc.'s OSHA DART read is graded against its sector.
- H-1B salary negotiation - using disclosed wages like Alexion Pharmaceuticals, Inc.'s when you negotiate.
- Compare employers - put Alexion Pharmaceuticals, Inc. next to peers on pay, safety, and WARN.
- National H-1B & safety statistics - where Alexion Pharmaceuticals, Inc.'s #1,437 placement sits in the full federal roster.
Retrieved and formatted by PlainEmployers.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Frequently Asked Questions
Where does Alexion Pharmaceuticals, Inc.'s H-1B wage sit nationally?
Among 272,125 credible H-1B wage rows in this corpus, Alexion Pharmaceuticals, Inc.'s disclosed median of $169,770 sits at the 79th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
How does Alexion Pharmaceuticals, Inc.'s H-1B filing volume compare to other sponsors?
Alexion Pharmaceuticals, Inc. has 34 H-1B filings on record, ranking #1,437 of 51,370 sponsors in this corpus (about the 97th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
What does Alexion Pharmaceuticals, Inc.'s OSHA safety grade mean?
Alexion Pharmaceuticals, Inc. carries Grade A from its establishment injury record (3 injuries on file; DART 0.09). That DART rate is safer than roughly 63% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.